Cancer Immunology: Across Space & Time
openNCI - National Cancer Institute
PROJECT SUMMARY
Cancer Immunology: Across Space & Time is an international scientific conference that will convene leaders
and early-career investigators in cancer immunology, tumor biology, systems immunology, and computational
biology to address how tumor–immune interactions evolve over space and time. Despite transformative
successes of immune checkpoint inhibitors and related therapies, many patients still fail to respond or develop
resistance. A critical unmet need is to understand how dynamic networks of immune, stromal, and tumor cells
across anatomic sites (primary tumor, metastases, peripheral lymphoid organs) collectively shape anti-tumor
immunity and therapeutic outcomes.
The meeting will be held July 10–13, 2026, in Lisbon, Portugal, and is organized by Drs. Amanda W. Lund (NYU
Grossman School of Medicine), Greg Delgoffe (University of Pittsburgh), and Nikhil Joshi (Yale University). The
program is organized into six thematic sessions: Mapping Tumor: Immune Evolution; The Influence of Micro-
and Macro-environments; Intratumoral Heterogeneity and Immunotherapy; Modeling Immune Responses in
Cancer; Linking Local and Systemic Immunity; and Deconstructing Immune Dynamics in Tissues, with invited
speakers from leading institutions worldwide and multiple short talks selected from submitted abstracts.
Support is requested from NCI under PA-25-080 to offset registration costs for key, US-based invited speakers
and to provide young investigator awards that incentivize trainees and early-career faculty to attend and present
their work. NYU Grossman School of Medicine will serve as the U.S. applicant institution, and Fusion
Conferences will provide logistical support as a commercial meeting organizer. The conference will emphasize
inclusivity, a safe and harassment-free environment, and attention to family-care needs. By integrating
mechanistic immunology, vascular and stromal biology, spatial and temporal omics, and computational
modeling, this meeting will catalyze new collaborations and conceptual advances that directly support NIH’s
mission to improve cancer outcomes through more effective immunotherapy.
Up to $15K
health research